Literature DB >> 422227

The effect of heat inactivation of serum on aggregation of immunoglobulins.

R D Soltis, D Hasz, M J Morris, I D Wilson.   

Abstract

Heating serum at 56 degrees is used to inactivate complement in several immunological assays. During heating, both heat-labile and heat-stable anticomplementary activity (ACA) develop. While heat-labile ACA can be completely inactivated, heat-stable ACA increases progressively with continued heating. Heat-stable ACA develops in deaggregated IgG and in normal, but not in hypogammaglobulinaemic, human and porcine serum heated at 56 degrees suggesting that this ACA is due to formation of immunoglobulin aggregates. These aggregates would produce false-positive tests for immune complexes and could inhibit a variety of cell-mediated reactions in assays which incorporate heat-inactivated serum. Other temperatures were tested to determine whether endogenous haemolytic activity could be destroyed without forming immunoglobulin aggregates. At 53 degrees both endogenous haemolytic activity and heat-labile ACA were inactivated and formation of heat-stable ACA in normal serum was minimal. ACA, however, could be induced in deaggregated IgG at 53 degrees. Moreover, the degree of heat-induced aggregation of IgG in vitro at either temperature was directly proportional to IgG concentrations and inversely related to albumin concentrations. Thus, pathological sera with these protein alterations might form more aggregates during heating than normal sera. These data suggest the following: (1) heat inactivation of complement at 53 degrees for 90 min is preferable to the traditional 56 degrees; (2) in any assay where immunoglobulin aggregates might interfere, normal serum may be an inadequate control and correlations will need to be made between serum IgG and albumin concentrations and the results obtained in these assays.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 422227      PMCID: PMC1457381     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  4 in total

1.  The role of aggregated gamma-globulins in the anticomplementary activity of human and animal sera.

Authors:  L H FROMMHAGEN; H FUDENBERG
Journal:  J Immunol       Date:  1962-09       Impact factor: 5.422

2.  Detection and differentiation of immune complexes and IgG aggregates by a complement consumption assay.

Authors:  H Nielsen; S R Svehag
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-08

3.  The reactivity of rheumatoid factor with human gamma G globulin.

Authors:  C S Henney; D R Stanworth
Journal:  Immunology       Date:  1965-08       Impact factor: 7.397

4.  Detection of circulating immune complexes in pathological human sera.

Authors:  A H Johnson; J F Mowbray; K A Porter
Journal:  Lancet       Date:  1975-04-05       Impact factor: 79.321

  4 in total
  33 in total

1.  Longitudinal relationships between rheumatoid factor and cytokine expression by immunostimulated peripheral blood lymphocytes from patients with rheumatoid arthritis: New insights into B-cell activation.

Authors:  John M Davis; Cynthia S Crowson; Keith L Knutson; Sara J Achenbach; Michael A Strausbauch; Terry M Therneau; Eric L Matteson; Sherine E Gabriel; Peter J Wettstein
Journal:  Clin Immunol       Date:  2020-01-08       Impact factor: 3.969

2.  Characterization of antibodies mediating protection and cure of Trypanosoma musculi infection in mice.

Authors:  D S Wechsler; P A Kongshavn
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

3.  Single-Molecule Protein Detection in a Biofluid Using a Quantitative Nanopore Sensor.

Authors:  Avinash Kumar Thakur; Liviu Movileanu
Journal:  ACS Sens       Date:  2019-08-21       Impact factor: 7.711

4.  New Zealand White Rabbits Effectively Clear Borrelia burgdorferi B31 despite the Bacterium's Functional vlsE Antigenic Variation System.

Authors:  Maliha Batool; Andrew E Hillhouse; Yurij Ionov; Kelli J Kochan; Fatemeh Mohebbi; George Stoica; David W Threadgill; Alex Zelikovsky; Suryakant D Waghela; Dominique J Wiener; Artem S Rogovskyy
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

5.  Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum.

Authors:  Preeyaporn Monatrakul; Mathirut Mungthin; Arjen M Dondorp; Srivicha Krudsood; Rachanee Udomsangpetch; Polrat Wilairatana; Nicholas J White; Kesinee Chotivanich
Journal:  Malar J       Date:  2010-11-16       Impact factor: 2.979

6.  Natural hidden autoantibodies to tissue transglutaminase cross-react with fibrinogen.

Authors:  Ingrid M Zöller-Utz; Birgit Esslinger; Anja Schulze-Krebs; Walburga Dieterich
Journal:  J Clin Immunol       Date:  2009-11-27       Impact factor: 8.317

7.  Routine heat inactivation of serum reduces its capacity to promote cell attachment.

Authors:  D J Giard
Journal:  In Vitro Cell Dev Biol       Date:  1987-10

8.  Quantitation of in vitro opsonic activity of human antibody induced by a vaccine consisting of the type III-specific polysaccharide of group B streptococcus.

Authors:  B J De Cueninck; T K Eisenstein; T S McIntosh; G D Shockman; R M Swenson
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

9.  Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI.

Authors:  Fabian Bohländer; Dennis Riehl; Sabrina Weißmüller; Marcus Gutscher; Jörg Schüttrumpf; Stefanie Faust
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

10.  Differential effects of serum heat treatment on chemotaxis and phagocytosis by human neutrophils.

Authors:  Alexander R Mankovich; Cheng-Yuk Lee; Volkmar Heinrich
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.